Cite

HARVARD Citation

    Dong, Y. et al. (2020). Who may benefit from lower dosages of intravenous tissue plasminogen activator? Results from a cluster data analysis. Stroke and vascular neurology. 5 (4), pp. 348-352. [Online]. 
  
Back to record